Digital Content 
NEWS #PharmaBuzz
18 Oct 2024
// PRESS RELEASE
https://news.abbvie.com/2024-10-17-U-S-FDA-Approves-VYALEV-TM-foscarbidopa-and-foslevodopa-for-Adults-Living-with-Advanced-Parkinsons-Disease
09 Jan 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/abbvie-launches-produodopa-foslevodopafoscarbidopa-for-people-living-with-advanced-parkinsons-disease-in-the-european-union-302028989.html
17 Sep 2022
// PRESS RELEASE
https://news.abbvie.com/news/press-releases/abbvie-to-present-data-from-growing-neuroscience-and-movement-disorders-portfolio-at-2022-mds-international-congress.htm
21 May 2022
// BIOSPACE
https://www.biospace.com/article/abbvie-submits-new-drug-application-to-u-s-fda-for-investigational-abbv-951-foscarbidopa-foslevodopa-for-the-treatment-of-advanced-parkinson-s-disease/
LOOKING FOR A SUPPLIER?
Share